Lihong Li, Chief Physician

Lihong Li
Chief Physician
Department of Hematology
Beijing Chaoyang Hospital

EXPERTISE: The main research directions include the research and treatment of platelets and coagulation diseases, the basic and clinical research of multiple myeloma, the basic and clinical research of tumor hypercoagulability, and the diagnosis and treatment of difficult cases of hematological diseases. Extensive research on the treatment of refractory thrombocytopenic purpura; developed hypercoagulable mechanisms for multiple myeloma, lymphoma and other hematological malignancies, as well as myeloproliferative diseases (including polycythemia vera, thrombocythemia, etc.) , research on clinically effective prevention and treatment; has rich experience in early diagnosis and timing of treatment of multiple myeloma, mainly including: chemotherapy, hematopoietic stem cell transplantation, immunotherapy, anti-angiogenesis treatment, bone disease treatment and anti- Coagulation therapy, etc., has extended the overall survival period of patients from the internationally recognized 3-4 years to 4-5 years, and some patients have long-term survival..

KEYWORDS: General, blood disease

More Doctors

Ying Xu Chief Physician, Professor Special Needs Hematology Department Peking Union Medical College Hospital

Minjing Yang Deputy Chief Physician General Medical Department Beijing Anzhen Hospital

Lina Zhang Deputy Chief Physician Department of Hematology China Academy of Chinese Medical Sciences Guang'anmen Hospital

Qian Jiang Chief Physician, Associate Professor Department of Hematology Peking University People's Hospital

Rongsheng Li Chief Physician, Doctoral Supervisor Department of Hematology Peking Union Medical College Hospital